- Home
- FPI vs HUMA Comparison
FPI vs HUMA Comparison
Compare FPI & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FPI
- HUMA
- Stock Information
- Founded
- FPI 2013
- HUMA 2004
- Country
- FPI United States
- HUMA United States
- Employees
- FPI N/A
- HUMA N/A
- Industry
- FPI Real Estate Investment Trusts
- HUMA Biotechnology: Pharmaceutical Preparations
- Sector
- FPI Real Estate
- HUMA Health Care
- Exchange
- FPI Nasdaq
- HUMA Nasdaq
- Market Cap
- FPI 478.7M
- HUMA 250.2M
- IPO Year
- FPI 2014
- HUMA N/A
- Fundamental
- Price
- FPI $11.02
- HUMA $1.85
- Analyst Decision
- FPI
- HUMA Strong Buy
- Analyst Count
- FPI 0
- HUMA 8
- Target Price
- FPI N/A
- HUMA $10.88
- AVG Volume (30 Days)
- FPI 275.3K
- HUMA 2.9M
- Earning Date
- FPI 10-29-2025
- HUMA 11-07-2025
- Dividend Yield
- FPI 2.17%
- HUMA N/A
- EPS Growth
- FPI 229.01
- HUMA N/A
- EPS
- FPI 1.21
- HUMA N/A
- Revenue
- FPI $55,000,000.00
- HUMA $818,000.00
- Revenue This Year
- FPI N/A
- HUMA N/A
- Revenue Next Year
- FPI N/A
- HUMA $1,619.38
- P/E Ratio
- FPI $9.17
- HUMA N/A
- Revenue Growth
- FPI N/A
- HUMA N/A
- 52 Week Low
- FPI $9.66
- HUMA $1.15
- 52 Week High
- FPI $12.87
- HUMA $6.77
- Technical
- Relative Strength Index (RSI)
- FPI 55.33
- HUMA 58.85
- Support Level
- FPI $10.82
- HUMA $1.45
- Resistance Level
- FPI $11.15
- HUMA $1.53
- Average True Range (ATR)
- FPI 0.18
- HUMA 0.10
- MACD
- FPI 0.03
- HUMA 0.06
- Stochastic Oscillator
- FPI 75.59
- HUMA 93.88
About FPI Farmland Partners Inc.
Farmland Partners Inc owns and seeks to acquire high-quality farmland throughout North America. The company is an internally managed real estate company which owns and contracts farmland and storage facilities located across the United States. Majority of the properties in its portfolio are used to grow primary crops, such as corn, soybeans, wheat, rice and cotton, and rest to produce specialty crops, such as almonds, pictachios, citrus, avacados, strawberies, and edible beans. The company generates its revenues through the rent it receives from its tenants.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.